Podcast: Sten R. Sörenson, Cereno Scientific 🇸🇪 | Drug Repurposing, Retail Investors on the Flot.bio podcast with Philip Hemme

CEO Sten R. Sörensen talks to Philip Hemme, Flot.bio

Sten R. Sörensen, CEO, sat down to discuss Cereno Scientific’s pipeline potential, future plans and much more in the latest episode of the Flot.bio Show with Philip Hemme, the number one biotech podcast in Europe.

The episode provides a comprehensive story of how the company’s clinical pipeline came to be, the sharp strategy behind drug repurposing in rare disease and where we are at today - soon entering a Phase IIb trial with the support of thousands of engaged retail investors.

Watch here >